Olamide Olawoyin

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis”.

Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis

Cell(2021)10.1016/j.cell.2021.01.022

N/A

0.897DataRank · unranked

394 citations

Orr Ashenberg, Itay Tirosh, Simon Gritsch, Elizabeth M. Perez, Sascha Marx +38 more

Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells

The Journal of Experimental Medicine(2020)10.1084/jem.20191453

N/A

0DataRank · unranked

69 citations

Olamide Olawoyin, Paloma Cejas, Yingtian Xie, Clifford A. Meyer, Yoshinaga Ito +7 more

Worse overall health status negatively impacts satisfaction with breast reconstruction

Journal of Plastic Reconstructive & Aesthetic Surgery(2020)10.1016/j.bjps.2020.08.093

N/A

0DataRank · unranked

11 citations

Olamide Olawoyin, Fouad Chouairi, Phan Q. Duy, Elbert J. Mets, Kyle S. Gabrick +4 more

CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1144

N/A

0DataRank · unranked

98 citations

Zexian Zeng, Archis Bagati, Rong En Tay, Lionel A. Sanz, Stella R. Hartono +17 more

Data from CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells

(2023)10.1158/2159-8290.c.6549178.v1

N/A

0DataRank · unranked

0 citations

Zexian Zeng, Archis Bagati, Rong En Tay, Lionel A. Sanz, Stella R. Hartono +17 more